APO Research
Talk to an analyst

APO RESEARCH · REPORT

GABA Receptor Agonist Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global GABA Receptor Agonist Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchGABA Receptor Agonist Drug Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal GABA Receptor Agonist Drug Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal GABA Receptor Agonist Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GABA Receptor Agonist Drug Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal GABA Receptor Agonist Drug Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global GABA Receptor Agonist Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for GABA Receptor Agonist Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for GABA Receptor Agonist Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GABA Receptor Agonist Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for GABA Receptor Agonist Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of GABA Receptor Agonist Drug include Novartis, Eli Lilly and Company, Pfizer, GlaxoSmithKline, AstraZeneca, XenoPort, VIVUS, sanofi-aventis and OVATION Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global GABA Receptor Agonist Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GABA Receptor Agonist Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GABA Receptor Agonist Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GABA Receptor Agonist Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

GABA Receptor Agonist Drug Segment by Company

Novartis

Eli Lilly and Company

Pfizer

GlaxoSmithKline

AstraZeneca

XenoPort

VIVUS

sanofi-aventis

OVATION Pharmaceuticals

Osmotica Pharmaceutical

NovaDel Pharma

H.LundBeck, Merck and Co

Elan Corporation

Biocodex

Athena Drug Delivery Solutions

Advicenne

GABA Receptor Agonist Drug Segment by Type

Baclofen

Bamaluzole

Phenibut

Gaboxadol

Klonopin (clonazepam)

Tiagbine

GABA Receptor Agonist Drug Segment by Application

Alzheimer

Epilepsy and Seizure

Obesity and Alcoholism

Anxiety and Sleep Disorders

Psychiatric Disorders and Depression

Attention Deficit Hyperactivity Disorder (ADHD)

GABA Receptor Agonist Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABA Receptor Agonist Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GABA Receptor Agonist Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABA Receptor Agonist Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the GABA Receptor Agonist Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of GABA Receptor Agonist Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of GABA Receptor Agonist Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of GABA Receptor Agonist Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. GABA Receptor Agonist Drug Industry Trends Table 2. GABA Receptor Agonist Drug Industry Drivers Table 3. GABA Receptor Agonist Drug Industry Opportunities and Challenges Table 4. GABA Receptor Agonist Drug Industry Restraints Table 5. Global GABA Receptor Agonist Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global GABA Receptor Agonist Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global GABA Receptor Agonist Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global GABA Receptor Agonist Drug Sales Market Share by Manufacturers Table 9. Global GABA Receptor Agonist Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global GABA Receptor Agonist Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global GABA Receptor Agonist Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global GABA Receptor Agonist Drug Manufacturers, Product Type & Application Table 13. Global GABA Receptor Agonist Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global GABA Receptor Agonist Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Baclofen Table 17. Major Manufacturers of Bamaluzole Table 18. Major Manufacturers of Phenibut Table 19. Major Manufacturers of Gaboxadol Table 20. Major Manufacturers of Klonopin (clonazepam) Table 21. Major Manufacturers of Tiagbine Table 22. Global GABA Receptor Agonist Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global GABA Receptor Agonist Drug Sales by Type (2021-2026) & (k units) Table 24. Global GABA Receptor Agonist Drug Sales by Type (2027-2032) & (k units) Table 25. Global GABA Receptor Agonist Drug Sales Market Share by Type (2021-2026) Table 26. Global GABA Receptor Agonist Drug Sales Market Share by Type (2027-2032) Table 27. Global GABA Receptor Agonist Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 28. Global GABA Receptor Agonist Drug Revenue by Type (2021-2026) & (k units) Table 29. Global GABA Receptor Agonist Drug Revenue by Type (2027-2032) & (k units) Table 30. Global GABA Receptor Agonist Drug Revenue Market Share by Type (2021-2026) Table 31. Global GABA Receptor Agonist Drug Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Alzheimer Table 33. Major Manufacturers of Epilepsy and Seizure Table 34. Major Manufacturers of Obesity and Alcoholism Table 35. Major Manufacturers of Anxiety and Sleep Disorders Table 36. Major Manufacturers of Psychiatric Disorders and Depression Table 37. Major Manufacturers of Attention Deficit Hyperactivity Disorder (ADHD) Table 38. Global GABA Receptor Agonist Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global GABA Receptor Agonist Drug Sales by Application (2021-2026) & (k units) Table 40. Global GABA Receptor Agonist Drug Sales by Application (2027-2032) & (k units) Table 41. Global GABA Receptor Agonist Drug Sales Market Share by Application (2021-2026) Table 42. Global GABA Receptor Agonist Drug Sales Market Share by Application (2027-2032) Table 43. Global GABA Receptor Agonist Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 44. Global GABA Receptor Agonist Drug Revenue by Application (2021-2026) & (k units) Table 45. Global GABA Receptor Agonist Drug Revenue by Application (2027-2032) & (k units) Table 46. Global GABA Receptor Agonist Drug Revenue Market Share by Application (2021-2026) Table 47. Global GABA Receptor Agonist Drug Revenue Market Share by Application (2027-2032) Table 48. Global GABA Receptor Agonist Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 49. Global GABA Receptor Agonist Drug Sales by Region (2021-2026) & (k units) Table 50. Global GABA Receptor Agonist Drug Sales Market Share by Region (2021-2026) Table 51. Global GABA Receptor Agonist Drug Sales Forecasted by Region (2027-2032) & (k units) Table 52. Global GABA Receptor Agonist Drug Sales Forecasted Market Share by Region (2027-2032) Table 53. North America GABA Receptor Agonist Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. North America GABA Receptor Agonist Drug Sales by Country (2021-2026) & (k units) Table 55. North America GABA Receptor Agonist Drug Sales by Country (2027-2032) & (k units) Table 56. Europe GABA Receptor Agonist Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Europe GABA Receptor Agonist Drug Sales by Country (2021-2026) & (k units) Table 58. Europe GABA Receptor Agonist Drug Sales by Country (2027-2032) & (k units) Table 59. Asia Pacific GABA Receptor Agonist Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. Asia Pacific GABA Receptor Agonist Drug Sales by Country (2021-2026) & (k units) Table 61. Asia Pacific GABA Receptor Agonist Drug Sales by Country (2027-2032) & (k units) Table 62. South America, Middle East and Africa GABA Receptor Agonist Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 63. South America, Middle East and Africa GABA Receptor Agonist Drug Sales by Country (2021-2026) & (k units) Table 64. South America, Middle East and Africa GABA Receptor Agonist Drug Sales by Country (2027-2032) & (k units) Table 65. Global GABA Receptor Agonist Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 66. Global GABA Receptor Agonist Drug Revenue by Region (2021-2026) & (US$ Million) Table 67. Global GABA Receptor Agonist Drug Revenue by Region (2027-2032) & (US$ Million) Table 68. Global GABA Receptor Agonist Drug Revenue Market Share by Region (2021-2026) Table 69. Global GABA Receptor Agonist Drug Revenue Market Share by Region (2027-2032) Table 70. Novartis Company Information Table 71. Novartis Business Overview Table 72. Novartis GABA Receptor Agonist Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Novartis GABA Receptor Agonist Drug Product Portfolio Table 74. Novartis Recent Development Table 75. Eli Lilly and Company Company Information Table 76. Eli Lilly and Company Business Overview Table 77. Eli Lilly and Company GABA Receptor Agonist Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Eli Lilly and Company GABA Receptor Agonist Drug Product Portfolio Table 79. Eli Lilly and Company Recent Development Table 80. Pfizer Company Information Table 81. Pfizer Business Overview Table 82. Pfizer GABA Receptor Agonist Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Pfizer GABA Receptor Agonist Drug Product Portfolio Table 84. Pfizer Recent Development Table 85. GlaxoSmithKline Company Information Table 86. GlaxoSmithKline Business Overview Table 87. GlaxoSmithKline GABA Receptor Agonist Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. GlaxoSmithKline GABA Receptor Agonist Drug Product Portfolio Table 89. GlaxoSmithKline Recent Development Table 90. AstraZeneca Company Information Table 91. AstraZeneca Business Overview Table 92. AstraZeneca GABA Receptor Agonist Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. AstraZeneca GABA Receptor Agonist Drug Product Portfolio Table 94. AstraZeneca Recent Development Table 95. XenoPort Company Information Table 96. XenoPort Business Overview Table 97. XenoPort GABA Receptor Agonist Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. XenoPort GABA Receptor Agonist Drug Product Portfolio Table 99. XenoPort Recent Development Table 100. VIVUS Company Information Table 101. VIVUS Business Overview Table 102. VIVUS GABA Receptor Agonist Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. VIVUS GABA Receptor Agonist Drug Product Portfolio Table 104. VIVUS Recent Development Table 105. sanofi-aventis Company Information Table 106. sanofi-aventis Business Overview Table 107. sanofi-aventis GABA Receptor Agonist Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. sanofi-aventis GABA Receptor Agonist Drug Product Portfolio Table 109. sanofi-aventis Recent Development Table 110. OVATION Pharmaceuticals Company Information Table 111. OVATION Pharmaceuticals Business Overview Table 112. OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. OVATION Pharmaceuticals GABA Receptor Agonist Drug Product Portfolio Table 114. OVATION Pharmaceuticals Recent Development Table 115. Osmotica Pharmaceutical Company Information Table 116. Osmotica Pharmaceutical Business Overview Table 117. Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Osmotica Pharmaceutical GABA Receptor Agonist Drug Product Portfolio Table 119. Osmotica Pharmaceutical Recent Development Table 120. NovaDel Pharma Company Information Table 121. NovaDel Pharma Business Overview Table 122. NovaDel Pharma GABA Receptor Agonist Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. NovaDel Pharma GABA Receptor Agonist Drug Product Portfolio Table 124. NovaDel Pharma Recent Development Table 125. H.LundBeck, Merck and Co Company Information Table 126. H.LundBeck, Merck and Co Business Overview Table 127. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product Portfolio Table 129. H.LundBeck, Merck and Co Recent Development Table 130. Elan Corporation Company Information Table 131. Elan Corporation Business Overview Table 132. Elan Corporation GABA Receptor Agonist Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Elan Corporation GABA Receptor Agonist Drug Product Portfolio Table 134. Elan Corporation Recent Development Table 135. Biocodex Company Information Table 136. Biocodex Business Overview Table 137. Biocodex GABA Receptor Agonist Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Biocodex GABA Receptor Agonist Drug Product Portfolio Table 139. Biocodex Recent Development Table 140. Athena Drug Delivery Solutions Company Information Table 141. Athena Drug Delivery Solutions Business Overview Table 142. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product Portfolio Table 144. Athena Drug Delivery Solutions Recent Development Table 145. Advicenne Company Information Table 146. Advicenne Business Overview Table 147. Advicenne GABA Receptor Agonist Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Advicenne GABA Receptor Agonist Drug Product Portfolio Table 149. Advicenne Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. GABA Receptor Agonist Drug Distributors List Table 153. GABA Receptor Agonist Drug Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. GABA Receptor Agonist Drug Product Image Figure 2. Global GABA Receptor Agonist Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GABA Receptor Agonist Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global GABA Receptor Agonist Drug Sales (2021-2032) & (k units) Figure 5. Global GABA Receptor Agonist Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 GABA Receptor Agonist Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Baclofen Image Figure 9. Bamaluzole Image Figure 10. Phenibut Image Figure 11. Gaboxadol Image Figure 12. Klonopin (clonazepam) Image Figure 13. Tiagbine Image Figure 14. Global GABA Receptor Agonist Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global GABA Receptor Agonist Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global GABA Receptor Agonist Drug Sales Market Share by Type (2021-2032) Figure 17. Global GABA Receptor Agonist Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global GABA Receptor Agonist Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global GABA Receptor Agonist Drug Revenue Market Share by Type (2021-2032) Figure 20. Alzheimer Image Figure 21. Epilepsy and Seizure Image Figure 22. Obesity and Alcoholism Image Figure 23. Anxiety and Sleep Disorders Image Figure 24. Psychiatric Disorders and Depression Image Figure 25. Attention Deficit Hyperactivity Disorder (ADHD) Image Figure 26. Global GABA Receptor Agonist Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global GABA Receptor Agonist Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 28. Global GABA Receptor Agonist Drug Sales Market Share by Application (2021-2032) Figure 29. Global GABA Receptor Agonist Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 30. Global GABA Receptor Agonist Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 31. Global GABA Receptor Agonist Drug Revenue Market Share by Application (2021-2032) Figure 32. North America GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 33. North America GABA Receptor Agonist Drug Sales Market Share by Country (2021-2032) Figure 34. U.S. GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 35. Canada GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 36. Mexico GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 37. Europe GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 38. Europe GABA Receptor Agonist Drug Sales Market Share by Country (2021-2032) Figure 39. Germany GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 40. France GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 41. U.K. GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 42. Italy GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 43. Netherlands GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 44. Asia Pacific GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. Asia Pacific GABA Receptor Agonist Drug Sales Market Share by Country (2021-2032) Figure 46. China GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 47. Japan GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Korea GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 49. Southeast Asia GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 50. India GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 51. Australia GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 52. South America, Middle East and Africa GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. South America, Middle East and Africa GABA Receptor Agonist Drug Sales Market Share by Country (2021-2032) Figure 54. Brazil GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 55. South Africa GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 56. Saudi Arabia GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 57. Turkey GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 58. Argentina GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 59. UAE GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 60. Egypt GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 61. Chile GABA Receptor Agonist Drug Sales and Growth Rate (2021-2032) & (k units) Figure 62. Global GABA Receptor Agonist Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Global GABA Receptor Agonist Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 64. North America GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Figure 65. North America GABA Receptor Agonist Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Europe GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Figure 67. Europe GABA Receptor Agonist Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Asia-Pacific GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Figure 69. Asia-Pacific GABA Receptor Agonist Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. South America, Middle East and Africa GABA Receptor Agonist Drug Revenue (2021-2032) & (US$ Million) Figure 71. South America, Middle East and Africa GABA Receptor Agonist Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. GABA Receptor Agonist Drug Value Chain Figure 73. Manufacturing Cost Structure Figure 74. GABA Receptor Agonist Drug Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Baclofen
  • Bamaluzole
  • Phenibut
  • Gaboxadol
  • Klonopin (clonazepam)
  • Tiagbine
Applications
  • Alzheimer
  • Epilepsy and Seizure
  • Obesity and Alcoholism
  • Anxiety and Sleep Disorders
  • Psychiatric Disorders and Depression
  • Attention Deficit Hyperactivity Disorder (ADHD)
Companies covered
  • Novartis
  • Eli Lilly and Company
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • XenoPort
  • VIVUS
  • sanofi-aventis
  • OVATION Pharmaceuticals
  • Osmotica Pharmaceutical
  • NovaDel Pharma
  • H.LundBeck, Merck and Co
  • Elan Corporation
  • Biocodex
  • Athena Drug Delivery Solutions
  • Advicenne

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global GABA Receptor Agonist Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global GABA Receptor Agonist Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global GABA Receptor Agonist Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global GABA Receptor Agonist Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global GABA Receptor Agonist Drug Market Dynamics
  1. 2.1 GABA Receptor Agonist Drug Industry Trends
  2. 2.2 GABA Receptor Agonist Drug Industry Drivers
  3. 2.3 GABA Receptor Agonist Drug Industry Opportunities and Challenges
  4. 2.4 GABA Receptor Agonist Drug Industry Restraints
3 GABA Receptor Agonist Drug Market by Manufacturers
  1. 3.1 Global GABA Receptor Agonist Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global GABA Receptor Agonist Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global GABA Receptor Agonist Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global GABA Receptor Agonist Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global GABA Receptor Agonist Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global GABA Receptor Agonist Drug Manufacturers, Product Type & Application
  7. 3.7 Global GABA Receptor Agonist Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global GABA Receptor Agonist Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 GABA Receptor Agonist Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 GABA Receptor Agonist Drug Tier 1, Tier 2, and Tier 3
4 GABA Receptor Agonist Drug Market by Type
  1. 4.1 GABA Receptor Agonist Drug Type Introduction
  2. 4.1.1 Baclofen
  3. 4.1.2 Bamaluzole
  4. 4.1.3 Phenibut
  5. 4.1.4 Gaboxadol
  6. 4.1.5 Klonopin (clonazepam)
  7. 4.1.6 Tiagbine
  8. 4.2 Global GABA Receptor Agonist Drug Sales by Type
  9. 4.2.1 Global GABA Receptor Agonist Drug Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global GABA Receptor Agonist Drug Sales by Type (2021-2032)
  11. 4.2.3 Global GABA Receptor Agonist Drug Sales Market Share by Type (2021-2032)
  12. 4.3 Global GABA Receptor Agonist Drug Revenue by Type
  13. 4.3.1 Global GABA Receptor Agonist Drug Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global GABA Receptor Agonist Drug Revenue by Type (2021-2032)
  15. 4.3.3 Global GABA Receptor Agonist Drug Revenue Market Share by Type (2021-2032)
5 GABA Receptor Agonist Drug Market by Application
  1. 5.1 GABA Receptor Agonist Drug Application Introduction
  2. 5.1.1 Alzheimer
  3. 5.1.2 Epilepsy and Seizure
  4. 5.1.3 Obesity and Alcoholism
  5. 5.1.4 Anxiety and Sleep Disorders
  6. 5.1.5 Psychiatric Disorders and Depression
  7. 5.1.6 Attention Deficit Hyperactivity Disorder (ADHD)
  8. 5.2 Global GABA Receptor Agonist Drug Sales by Application
  9. 5.2.1 Global GABA Receptor Agonist Drug Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global GABA Receptor Agonist Drug Sales by Application (2021-2032)
  11. 5.2.3 Global GABA Receptor Agonist Drug Sales Market Share by Application (2021-2032)
  12. 5.3 Global GABA Receptor Agonist Drug Revenue by Application
  13. 5.3.1 Global GABA Receptor Agonist Drug Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global GABA Receptor Agonist Drug Revenue by Application (2021-2032)
  15. 5.3.3 Global GABA Receptor Agonist Drug Revenue Market Share by Application (2021-2032)
6 Global GABA Receptor Agonist Drug Sales by Region
  1. 6.1 Global GABA Receptor Agonist Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global GABA Receptor Agonist Drug Sales by Region (2021-2032)
  3. 6.2.1 Global GABA Receptor Agonist Drug Sales by Region (2021-2026)
  4. 6.2.2 Global GABA Receptor Agonist Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America GABA Receptor Agonist Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America GABA Receptor Agonist Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe GABA Receptor Agonist Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe GABA Receptor Agonist Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific GABA Receptor Agonist Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific GABA Receptor Agonist Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa GABA Receptor Agonist Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa GABA Receptor Agonist Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global GABA Receptor Agonist Drug Revenue by Region
  1. 7.1 Global GABA Receptor Agonist Drug Revenue by Region
  2. 7.1.1 Global GABA Receptor Agonist Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global GABA Receptor Agonist Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global GABA Receptor Agonist Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global GABA Receptor Agonist Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America GABA Receptor Agonist Drug Revenue (2021-2032)
  8. 7.2.2 North America GABA Receptor Agonist Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe GABA Receptor Agonist Drug Revenue (2021-2032)
  11. 7.3.2 Europe GABA Receptor Agonist Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific GABA Receptor Agonist Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific GABA Receptor Agonist Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa GABA Receptor Agonist Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa GABA Receptor Agonist Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis GABA Receptor Agonist Drug Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Eli Lilly and Company
  8. 8.2.1 Eli Lilly and Company Company Information
  9. 8.2.2 Eli Lilly and Company Business Overview
  10. 8.2.3 Eli Lilly and Company GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly and Company GABA Receptor Agonist Drug Product Portfolio
  12. 8.2.5 Eli Lilly and Company Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer GABA Receptor Agonist Drug Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 GlaxoSmithKline
  20. 8.4.1 GlaxoSmithKline Company Information
  21. 8.4.2 GlaxoSmithKline Business Overview
  22. 8.4.3 GlaxoSmithKline GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline GABA Receptor Agonist Drug Product Portfolio
  24. 8.4.5 GlaxoSmithKline Recent Developments
  25. 8.5 AstraZeneca
  26. 8.5.1 AstraZeneca Company Information
  27. 8.5.2 AstraZeneca Business Overview
  28. 8.5.3 AstraZeneca GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AstraZeneca GABA Receptor Agonist Drug Product Portfolio
  30. 8.5.5 AstraZeneca Recent Developments
  31. 8.6 XenoPort
  32. 8.6.1 XenoPort Company Information
  33. 8.6.2 XenoPort Business Overview
  34. 8.6.3 XenoPort GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 XenoPort GABA Receptor Agonist Drug Product Portfolio
  36. 8.6.5 XenoPort Recent Developments
  37. 8.7 VIVUS
  38. 8.7.1 VIVUS Company Information
  39. 8.7.2 VIVUS Business Overview
  40. 8.7.3 VIVUS GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 VIVUS GABA Receptor Agonist Drug Product Portfolio
  42. 8.7.5 VIVUS Recent Developments
  43. 8.8 sanofi-aventis
  44. 8.8.1 sanofi-aventis Company Information
  45. 8.8.2 sanofi-aventis Business Overview
  46. 8.8.3 sanofi-aventis GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 sanofi-aventis GABA Receptor Agonist Drug Product Portfolio
  48. 8.8.5 sanofi-aventis Recent Developments
  49. 8.9 OVATION Pharmaceuticals
  50. 8.9.1 OVATION Pharmaceuticals Company Information
  51. 8.9.2 OVATION Pharmaceuticals Business Overview
  52. 8.9.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 OVATION Pharmaceuticals GABA Receptor Agonist Drug Product Portfolio
  54. 8.9.5 OVATION Pharmaceuticals Recent Developments
  55. 8.10 Osmotica Pharmaceutical
  56. 8.10.1 Osmotica Pharmaceutical Company Information
  57. 8.10.2 Osmotica Pharmaceutical Business Overview
  58. 8.10.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Osmotica Pharmaceutical GABA Receptor Agonist Drug Product Portfolio
  60. 8.10.5 Osmotica Pharmaceutical Recent Developments
  61. 8.11 NovaDel Pharma
  62. 8.11.1 NovaDel Pharma Company Information
  63. 8.11.2 NovaDel Pharma Business Overview
  64. 8.11.3 NovaDel Pharma GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 NovaDel Pharma GABA Receptor Agonist Drug Product Portfolio
  66. 8.11.5 NovaDel Pharma Recent Developments
  67. 8.12 H.LundBeck, Merck and Co
  68. 8.12.1 H.LundBeck, Merck and Co Company Information
  69. 8.12.2 H.LundBeck, Merck and Co Business Overview
  70. 8.12.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product Portfolio
  72. 8.12.5 H.LundBeck, Merck and Co Recent Developments
  73. 8.13 Elan Corporation
  74. 8.13.1 Elan Corporation Company Information
  75. 8.13.2 Elan Corporation Business Overview
  76. 8.13.3 Elan Corporation GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Elan Corporation GABA Receptor Agonist Drug Product Portfolio
  78. 8.13.5 Elan Corporation Recent Developments
  79. 8.14 Biocodex
  80. 8.14.1 Biocodex Company Information
  81. 8.14.2 Biocodex Business Overview
  82. 8.14.3 Biocodex GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Biocodex GABA Receptor Agonist Drug Product Portfolio
  84. 8.14.5 Biocodex Recent Developments
  85. 8.15 Athena Drug Delivery Solutions
  86. 8.15.1 Athena Drug Delivery Solutions Company Information
  87. 8.15.2 Athena Drug Delivery Solutions Business Overview
  88. 8.15.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product Portfolio
  90. 8.15.5 Athena Drug Delivery Solutions Recent Developments
  91. 8.16 Advicenne
  92. 8.16.1 Advicenne Company Information
  93. 8.16.2 Advicenne Business Overview
  94. 8.16.3 Advicenne GABA Receptor Agonist Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Advicenne GABA Receptor Agonist Drug Product Portfolio
  96. 8.16.5 Advicenne Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 GABA Receptor Agonist Drug Value Chain Analysis
  2. 9.1.1 GABA Receptor Agonist Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 GABA Receptor Agonist Drug Production Mode & Process
  6. 9.2 GABA Receptor Agonist Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 GABA Receptor Agonist Drug Distributors
  9. 9.2.3 GABA Receptor Agonist Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst